Patent · US Active

Use of Salvia miltiorrhiza composition in preparing drugs for secondary prevention of coronary heart disease

US9072745B2 · kind B2 · utility

2Cited by

2References

28Claims

0Family size

Assignee

TASLY PHARMACEUTICAL GROUP CO., LTD. · CN

Inventors

Xijun Yan · Tianjin, CN
Naifeng Wu · Tianjin, CN
Kaijing Yan · Tianjin, CN
He Sun · Shanghai, CN
Zhixin Guo · Tianjin, CN
Guoguang Zhu · Tianjin, CN
Weiwei Liu · Lo Wu, CN
Libin Zhao · Chengdu, CN
Ruizhi Luo · Tianjin, CN

Key dates

Filing date	Aug 8, 2011
Grant date	Jul 7, 2015
Priority date	—
Expiry date	Aug 8, 2031

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P43/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Provided is the use of a Salvia Miltiorrhiza composition in preparing drugs for secondary prevention of coronary heart disease, and particularly the use of the Salvia Miltiorrhiza composition in preparing drugs for secondary prevention of stable angina type coronary heart disease and the reduction of serious vascular events.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.